Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbohydrate binding	CLEC18A MAN2B1 CLEC18B P3H3 CLEC18C BCAN CEMIP PLA2R1 FCN2 MRC2 ACAN PKD1 GAL3ST3 SIGLEC1	1.97e-07	310	159	14	GO:0030246
GeneOntologyMolecularFunction	polysaccharide binding	CLEC18A CLEC18B CLEC18C FCN2	1.03e-04	31	159	4	GO:0030247
GeneOntologyBiologicalProcess	positive regulation of protein kinase C activity	CEMIP NRXN1 EGFR AGT	1.23e-07	7	161	4	GO:1900020
GeneOntologyBiologicalProcess	regulation of protein kinase C activity	CEMIP NRXN1 EGFR AGT	1.23e-07	7	161	4	GO:1900019
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	ROBO4 PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2 TENM3 PKD1	2.19e-06	187	161	10	GO:0007156
GeneOntologyBiologicalProcess	neuron projection development	ROBO4 NPR2 CNTNAP1 DVL2 PCDHAC2 BCAN SPAG9 PTCH1 CSMD3 B4GALT6 SEMA3D STRN NOX1 CELSR2 NRXN1 MEGF8 TENM3 EGFR SIPA1L1 AVIL AGT CNTN3 NLGN2 HERC1 PLXNB1	2.14e-05	1285	161	25	GO:0031175
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	ROBO4 PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2 NRXN1 TENM3 PKD1	3.65e-05	313	161	11	GO:0098742
GeneOntologyBiologicalProcess	negative regulation of apoptotic process involved in outflow tract morphogenesis	FOXC1 FOXC2	6.06e-05	2	161	2	GO:1902257
GeneOntologyBiologicalProcess	neuron development	ROBO4 NPR2 CNTNAP1 DVL2 PCDHAC2 BCAN SPAG9 ATP8B1 PTCH1 CSMD3 B4GALT6 SEMA3D STRN NOX1 CELSR2 NRXN1 MEGF8 TENM3 EGFR SIPA1L1 AVIL AGT CNTN3 NLGN2 HERC1 PLXNB1	6.64e-05	1463	161	26	GO:0048666
GeneOntologyBiologicalProcess	lymph vessel development	NPR2 PKD1 FOXC1 FOXC2	1.08e-04	32	161	4	GO:0001945
GeneOntologyCellularComponent	extracellular matrix	COL6A1 COL6A2 DPT FRAS1 ADAMTS4 COL6A6 MMP21 BCAN OVGP1 FCGBP FCN2 ACAN AGT FGA USH2A	1.50e-04	656	159	15	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL6A1 COL6A2 DPT FRAS1 ADAMTS4 COL6A6 MMP21 BCAN OVGP1 FCGBP FCN2 ACAN AGT FGA USH2A	1.56e-04	658	159	15	GO:0030312
MousePheno	abnormal systemic artery morphology	PCDHA12 XPNPEP1 KL NOX1 MEGF8 EGFR ASB7 AGT PKD1 VAV3 FOXC1 FOXC2	2.25e-05	304	128	12	MP:0011655
MousePheno	abnormal rib morphology	FRAS1 NPR2 DVL2 PTCH1 KLHL5 KL ACAN WDR35 KMT2A FOXC1 FOXC2	2.39e-05	257	128	11	MP:0000150
MousePheno	abnormal aorta morphology	PCDHA12 KL NOX1 MEGF8 EGFR ASB7 PKD1 VAV3 FOXC1 FOXC2	4.14e-05	225	128	10	MP:0000272
Domain	Cadherin_tail	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	5.79e-07	37	156	6	PF15974
Domain	Cadherin_CBD	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	5.79e-07	37	156	6	IPR031904
Domain	EGF-like_dom	CLEC18A FRAS1 CLEC18B CNTNAP1 CLEC18C BCAN FCGBP CELSR2 NRXN1 MEGF8 TENM3 C1S	1.25e-06	249	156	12	IPR000742
Domain	C-type_lectin_CS	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2	1.46e-06	43	156	6	IPR018378
Domain	EGF	CLEC18A FRAS1 CLEC18B CNTNAP1 CLEC18C BCAN FCGBP CELSR2 NRXN1 MEGF8 TENM3	4.65e-06	235	156	11	SM00181
Domain	C_TYPE_LECTIN_1	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	4.72e-06	80	156	7	PS00615
Domain	Lectin_C	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	6.55e-06	84	156	7	PF00059
Domain	CLECT	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	6.55e-06	84	156	7	SM00034
Domain	C_TYPE_LECTIN_2	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	7.09e-06	85	156	7	PS50041
Domain	C-type_lectin-like	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	7.66e-06	86	156	7	IPR001304
Domain	EGF_1	CLEC18A CLEC18B CNTNAP1 CLEC18C BCAN CELSR2 NRXN1 MEGF8 TENM3 C1S USH2A	1.01e-05	255	156	11	PS00022
Domain	Cadherin_2	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.70e-05	65	156	6	PF08266
Domain	Cadherin_N	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.70e-05	65	156	6	IPR013164
Domain	-	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	1.70e-05	97	156	7	3.10.100.10
Domain	C-type_lectin-like/link	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	1.94e-05	99	156	7	IPR016186
Domain	EGF_3	CLEC18A CLEC18B CNTNAP1 CLEC18C BCAN CELSR2 NRXN1 MEGF8 TENM3 C1S	2.90e-05	235	156	10	PS50026
Domain	CTDL_fold	CLEC18A CLEC18B CLEC18C BCAN PLA2R1 MRC2 PKD1	3.21e-05	107	156	7	IPR016187
Domain	Cadherin_CS	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	3.62e-05	109	156	7	IPR020894
Domain	CADHERIN_1	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	4.56e-05	113	156	7	PS00232
Domain	Cadherin	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	4.56e-05	113	156	7	PF00028
Domain	CADHERIN_2	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	4.83e-05	114	156	7	PS50268
Domain	-	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	4.83e-05	114	156	7	2.60.40.60
Domain	CA	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	5.11e-05	115	156	7	SM00112
Domain	Cadherin-like	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	5.40e-05	116	156	7	IPR015919
Domain	Cadherin	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	6.02e-05	118	156	7	IPR002126
Domain	EGF-like_CS	CLEC18A CLEC18B CNTNAP1 CLEC18C BCAN CELSR2 NRXN1 MEGF8 TENM3 C1S	7.01e-05	261	156	10	IPR013032
Domain	EGF_2	CLEC18A CLEC18B CNTNAP1 CLEC18C BCAN CELSR2 NRXN1 MEGF8 TENM3 C1S	7.96e-05	265	156	10	PS01186
Domain	CAP	CLEC18A CLEC18B CLEC18C	2.42e-04	15	156	3	PF00188
Domain	SCP	CLEC18A CLEC18B CLEC18C	2.42e-04	15	156	3	SM00198
Domain	Allrgn_V5/Tpx1	CLEC18A CLEC18B CLEC18C	2.42e-04	15	156	3	IPR001283
Domain	-	CLEC18A CLEC18B CLEC18C	2.42e-04	15	156	3	3.40.33.10
Domain	CAP_domain	CLEC18A CLEC18B CLEC18C	2.42e-04	15	156	3	IPR014044
Domain	LAM_G_DOMAIN	CNTNAP1 CELSR2 NRXN1 USH2A	2.77e-04	38	156	4	PS50025
Domain	Laminin_G_2	CNTNAP1 CELSR2 NRXN1 USH2A	3.39e-04	40	156	4	PF02210
Domain	tRNA_hU_synthase_CS	DUS3L DUS1L	4.11e-04	4	156	2	IPR018517
Domain	tRNA_hU_synthase	DUS3L DUS1L	4.11e-04	4	156	2	IPR001269
Domain	UPF0034	DUS3L DUS1L	4.11e-04	4	156	2	PS01136
Domain	Dus	DUS3L DUS1L	4.11e-04	4	156	2	PF01207
Domain	LamG	CNTNAP1 CELSR2 NRXN1 USH2A	4.90e-04	44	156	4	SM00282
Domain	TLDc	OXR1 NCOA7	6.82e-04	5	156	2	SM00584
Domain	CAT3	SLC7A1 SLC7A4	6.82e-04	5	156	2	IPR015606
Domain	AA_permease_C	SLC7A1 SLC7A4	6.82e-04	5	156	2	PF13906
Domain	CAT_C	SLC7A1 SLC7A4	6.82e-04	5	156	2	IPR029485
Domain	AA-permease/SLC12A_dom	SLC7A1 SLC7A4 SLC12A7	7.83e-04	22	156	3	IPR004841
Domain	AA_permease	SLC7A1 SLC7A4 SLC12A7	7.83e-04	22	156	3	PF00324
Domain	TLDc_dom	OXR1 NCOA7	1.02e-03	6	156	2	IPR006571
Domain	LysM	OXR1 NCOA7	1.02e-03	6	156	2	PF01476
Domain	LysM_dom	OXR1 NCOA7	1.02e-03	6	156	2	IPR018392
Domain	LYSM	OXR1 NCOA7	1.02e-03	6	156	2	PS51782
Domain	-	OXR1 NCOA7	1.02e-03	6	156	2	3.10.350.10
Domain	TLD	OXR1 NCOA7	1.02e-03	6	156	2	PF07534
Domain	LysM	OXR1 NCOA7	1.02e-03	6	156	2	SM00257
Domain	Laminin_G	CNTNAP1 CELSR2 NRXN1 USH2A	1.40e-03	58	156	4	IPR001791
Domain	Fibrinogen_C	CNTNAP1 FCN2 FGA	1.44e-03	27	156	3	PF00147
Domain	FBG	CNTNAP1 FCN2 FGA	1.78e-03	29	156	3	SM00186
Domain	PyrdxlP-dep_de-COase	PDXDC1 HDC	1.88e-03	8	156	2	IPR002129
Domain	Pyridoxal_deC	PDXDC1 HDC	1.88e-03	8	156	2	PF00282
Domain	DDC_GAD_HDC_YDC	PDXDC1 HDC	1.88e-03	8	156	2	PS00392
Domain	-	CNTNAP1 FCN2 FGA	1.97e-03	30	156	3	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	CNTNAP1 FCN2 FGA	1.97e-03	30	156	3	IPR014716
Domain	EGF_LAM_2	CELSR2 MEGF8 USH2A	1.97e-03	30	156	3	PS50027
Domain	EGF_LAM_1	CELSR2 MEGF8 USH2A	1.97e-03	30	156	3	PS01248
Domain	Kringle-like	PRSS12 PLA2R1 MRC2	2.37e-03	32	156	3	IPR013806
Domain	FIBRINOGEN_C_1	CNTNAP1 FCN2 FGA	2.37e-03	32	156	3	PS00514
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP1 FCN2 FGA	2.37e-03	32	156	3	IPR002181
Domain	Plexin_repeat	SEMA3D MEGF8 PLXNB1	2.37e-03	32	156	3	IPR002165
Domain	FIBRINOGEN_C_2	CNTNAP1 FCN2 FGA	2.37e-03	32	156	3	PS51406
Domain	PSI	SEMA3D MEGF8 PLXNB1	2.37e-03	32	156	3	PF01437
Domain	Transglut_N	TGM6 TGM1	2.40e-03	9	156	2	PF00868
Domain	TRANSGLUTAMINASES	TGM6 TGM1	2.40e-03	9	156	2	PS00547
Domain	-	TGM6 TGM1	2.40e-03	9	156	2	3.90.260.10
Domain	Gln_gamma-glutamylTfrase_euk	TGM6 TGM1	2.40e-03	9	156	2	IPR023608
Domain	Transglutaminase_AS	TGM6 TGM1	2.40e-03	9	156	2	IPR013808
Domain	Transglutaminase_N	TGM6 TGM1	2.40e-03	9	156	2	IPR001102
Domain	Transglut_C	TGM6 TGM1	2.40e-03	9	156	2	PF00927
Domain	ConA-like_dom	CNTNAP1 CELSR2 NRXN1 MID1 SEL1L3 HERC1 USH2A	2.47e-03	219	156	7	IPR013320
Domain	Transglutaminase_C	TGM6 TGM1	2.99e-03	10	156	2	IPR008958
Domain	EGF_Lam	CELSR2 MEGF8 USH2A	3.08e-03	35	156	3	SM00180
Domain	Laminin_EGF	CELSR2 MEGF8 USH2A	3.08e-03	35	156	3	PF00053
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL6A1 COL6A2 COL6A6 BCAN ACAN	3.86e-05	47	115	5	MM14925
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL6A1 COL6A2 ADAMTS4 COL6A6 BCAN CAPN10 ACAN	4.01e-05	114	115	7	MM14571
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	5.78e-09	15	161	5	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.18e-08	17	161	5	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.63e-08	18	161	5	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.63e-08	18	161	5	10662547
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	4.57e-08	72	161	7	10380929
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	7.32e-08	77	161	7	10835267
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	7.91e-08	24	161	5	24698270
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 CELSR2	9.56e-08	80	161	7	10716726
Pubmed	The C-type lectin-like domain superfamily.	CLEC18A CLEC18B CLEC18C	9.74e-08	3	161	3	16336259
Pubmed	Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.	CLEC18A CLEC18B CLEC18C	9.74e-08	3	161	3	33603190
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18A CLEC18B CLEC18C	9.74e-08	3	161	3	26170455
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGC5 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.80e-07	28	161	5	15347688
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	2.68e-07	57	161	6	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	2.97e-07	58	161	6	30377227
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	ROBO4 CFAP95 FCGBP MEGF8 ACAN AGT FGA CNTN3 C1S PLXNB1	3.72e-07	257	161	10	16335952
Pubmed	The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.	CLEC18A CLEC18B CLEC18C	3.88e-07	4	161	3	16709836
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	7.74e-07	68	161	6	11230163
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A1 COL6A2 COL6A6	9.67e-07	5	161	3	23869615
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.28e-06	74	161	6	10817752
Pubmed	SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.	SEMA3D ACAN FOXC1 FOXC2	2.49e-06	21	161	4	30021842
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A1 COL6A2 COL6A6	3.36e-06	7	161	3	18400749
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A1 COL6A2 COL6A6	3.36e-06	7	161	3	18276594
Pubmed	Loss of Krox20 results in aortic valve regurgitation and impaired transcriptional activation of fibrillar collagen genes.	COL6A1 COL6A2 BCAN ACAN	4.37e-06	24	161	4	25344368
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	COL6A1 COL6A2 FRAS1	5.36e-06	8	161	3	12766770
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHGC5 PCDHAC2 PCDHA4	8.01e-06	9	161	3	12154121
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	COL6A1 COL6A2 FRAS1	1.14e-05	10	161	3	15345741
Pubmed	Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.	CES2 FCGBP EGFR AGT KMT2A LTC4S	1.16e-05	108	161	6	19956635
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	COL6A1 FRAS1 MAN2B1 P3H3 CNTNAP1 CYP51A1 RNF213 PLA2R1 FOXRED2 CELSR2 MEGF8 TENM3 EGFR MRC2 AGT CLPTM1 SEL1L3 PLXNB1	1.26e-05	1201	161	18	35696571
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA12 PCDHA7 PCDHA4	1.56e-05	11	161	3	9655502
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 TPRA1 MAN2B1 PTCH1 DUS1L PLEKHG1 ZGPAT SLC7A1 CELSR2 SSH1 MEGF8 PKD1 CACNA1H NLGN2 HERC1 HAS3 PRRT4	1.59e-05	1105	161	17	35748872
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	SLC25A6 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	2.02e-05	119	161	6	28625976
Pubmed	Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration.	FOXC1 FOXC2	2.13e-05	2	161	2	18187037
Pubmed	FOXC1 haploinsufficiency due to 6p25 deletion in a patient with rapidly progressing aortic valve disease.	FOXC1 FOXC2	2.13e-05	2	161	2	28657660
Pubmed	Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage.	NOX1 AGT	2.13e-05	2	161	2	21487074
Pubmed	The exon organization of the triple-helical coding regions of the human alpha 1(VI) and alpha 2(VI) collagen genes is highly similar.	COL6A1 COL6A2	2.13e-05	2	161	2	1765372
Pubmed	Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.	COL6A1 COL6A2	2.13e-05	2	161	2	33982770
Pubmed	Molecular characterization and bioinformatics analysis of Ncoa7B, a novel ovulation-associated and reproduction system-specific Ncoa7 isoform.	OXR1 NCOA7	2.13e-05	2	161	2	18299425
Pubmed	Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).	ADAMTS4 ACAN	2.13e-05	2	161	2	10751421
Pubmed	Ullrich disease due to deficiency of collagen VI in the sarcolemma.	COL6A1 COL6A2	2.13e-05	2	161	2	14981181
Pubmed	Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells.	SESN3 EGFR	2.13e-05	2	161	2	27881463
Pubmed	FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.	EGFR FOXC1	2.13e-05	2	161	2	25124473
Pubmed	Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy.	COL6A1 COL6A2	2.13e-05	2	161	2	19309692
Pubmed	Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype.	COL6A1 COL6A2	2.13e-05	2	161	2	11865138
Pubmed	Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.	FOXC1 FOXC2	2.13e-05	2	161	2	22493429
Pubmed	Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain.	ADAMTS4 BCAN	2.13e-05	2	161	2	18221525
Pubmed	MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.	ADAMTS4 ACAN	2.13e-05	2	161	2	22670872
Pubmed	Structural basis for DNA recognition by FOXC2.	FOXC1 FOXC2	2.13e-05	2	161	2	30722065
Pubmed	Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy.	COL6A1 COL6A2	2.13e-05	2	161	2	12374585
Pubmed	Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere's disease.	DPT SEMA3D	2.13e-05	2	161	2	27876815
Pubmed	The OXR domain defines a conserved family of eukaryotic oxidation resistance proteins.	OXR1 NCOA7	2.13e-05	2	161	2	17391516
Pubmed	Generation of conditional alleles for Foxc1 and Foxc2 in mice.	FOXC1 FOXC2	2.13e-05	2	161	2	22522965
Pubmed	Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.	DACT2 MME	2.13e-05	2	161	2	18370954
Pubmed	Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen).	COL6A1 COL6A2	2.13e-05	2	161	2	6852033
Pubmed	Foxc1 and Foxc2 are necessary to maintain glomerular podocytes.	FOXC1 FOXC2	2.13e-05	2	161	2	28223138
Pubmed	Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.	ADAMTS4 ACAN	2.13e-05	2	161	2	16188468
Pubmed	Expression of the mouse Fkh1/Mf1 and Mfh1 genes in late gestation embryos is restricted to mesoderm derivatives.	FOXC1 FOXC2	2.13e-05	2	161	2	9545561
Pubmed	Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes.	FOXC1 FOXC2	2.13e-05	2	161	2	33771836
Pubmed	ADAMTS-4_v1 is a splice variant of ADAMTS-4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain.	ADAMTS4 ACAN	2.13e-05	2	161	2	23897278
Pubmed	Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells.	NOX1 SSH1	2.13e-05	2	161	2	21857021
Pubmed	Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development.	FOXC1 FOXC2	2.13e-05	2	161	2	10767326
Pubmed	Characterization of Kidney and Skeleton Phenotypes of Mice Double Heterozygous for Foxc1 and Foxc2.	FOXC1 FOXC2	2.13e-05	2	161	2	27193493
Pubmed	Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus.	COL6A1 COL6A2	2.13e-05	2	161	2	2551668
Pubmed	Variants in FOXC1 and FOXC2 identified in patients with conotruncal heart defects.	FOXC1 FOXC2	2.13e-05	2	161	2	38580085
Pubmed	The transcription factor Foxc1 is necessary for Ihh-Gli2-regulated endochondral ossification.	PTCH1 FOXC1 FOXC2	3.41e-05	14	161	3	25808752
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	COL6A1 COL6A2 FRAS1	5.22e-05	16	161	3	16880404
Pubmed	Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.	NOX1 AGT	6.37e-05	3	161	2	22628375
Pubmed	TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers.	EGFR IKBKE	6.37e-05	3	161	2	24401319
Pubmed	Amino acid sequence of the triple-helical domain of human collagen type VI.	COL6A1 COL6A2	6.37e-05	3	161	2	3198591
Pubmed	Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).	AGT MME	6.37e-05	3	161	2	28559246
Pubmed	Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.	COL6A1 COL6A2	6.37e-05	3	161	2	8489506
Pubmed	Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.	COL6A1 COL6A2	6.37e-05	3	161	2	18366090
Pubmed	Collagen VI related muscle disorders.	COL6A1 COL6A2	6.37e-05	3	161	2	16141002
Pubmed	Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.	NOX1 EGFR	6.37e-05	3	161	2	22102727
Pubmed	Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges.	NRXN1 NLGN2	6.37e-05	3	161	2	28641112
Pubmed	Collagen VI-Related Dystrophies	COL6A1 COL6A2	6.37e-05	3	161	2	20301676
Pubmed	Tumor-specific overexpression of histone gene, H3C14 in gastric cancer is mediated through EGFR-FOXC1 axis.	EGFR FOXC1	6.37e-05	3	161	2	33727172
Pubmed	Collagen type VI myopathies.	COL6A1 COL6A2	6.37e-05	3	161	2	24443028
Pubmed	Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation.	FOXC1 FOXC2	6.37e-05	3	161	2	32510325
Pubmed	Expression of type VI collagen in the developing mouse heart.	COL6A1 COL6A2	6.37e-05	3	161	2	9520112
Pubmed	Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist.	NOX1 AGT	6.37e-05	3	161	2	15922295
Pubmed	Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.	COL6A1 COL6A2	6.37e-05	3	161	2	3348212
Pubmed	Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases.	CD3D KMT2A	6.37e-05	3	161	2	8327517
Pubmed	Pathogenesis of membranous nephropathy: recent advances and future challenges.	PLA2R1 MME	6.37e-05	3	161	2	22371247
Pubmed	Association of MARC1, ADCY5, and BCO1 Variants with the Lipid Profile, Suggests an Additive Effect for Hypertriglyceridemia in Mexican Adult Men.	ADCY5 BCO1	6.37e-05	3	161	2	36233117
Pubmed	Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway.	COL6A1 COL6A2	6.37e-05	3	161	2	21459131
Pubmed	Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes.	COL6A1 COL6A2	6.37e-05	3	161	2	36982625
Pubmed	New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.	COL6A1 COL6A2	6.37e-05	3	161	2	12840783
Pubmed	EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.	EGFR MME	6.37e-05	3	161	2	22300665
Pubmed	Quantitative evaluation of collagen type VI and SOD gene expression in the nuchal skin of human fetuses with trisomy 21.	COL6A1 COL6A2	6.37e-05	3	161	2	17602442
Pubmed	Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI.	COL6A1 COL6A2	6.37e-05	3	161	2	8168508
Pubmed	Expression of collagen alpha 1(VI), alpha 2(VI), and alpha 3(VI) chains in the pregnant mouse uterus.	COL6A1 COL6A2	6.37e-05	3	161	2	7780011
Pubmed	A TERT-CLPTM1 locus polymorphism (rs401681) is associated with EGFR mutation in non-small cell lung cancer.	EGFR CLPTM1	6.37e-05	3	161	2	29033187
Pubmed	Reactive oxygen species regulate a slingshot-cofilin activation pathway.	NOX1 SSH1	6.37e-05	3	161	2	19339277
Pubmed	Reactivity of renal and mesenteric resistance vessels to angiotensin II is mediated by NOXA1/NOX1 and superoxide signaling.	NOX1 AGT	6.37e-05	3	161	2	36759130
Pubmed	Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23).	NRXN1 KMT2A	6.37e-05	3	161	2	20113834
Pubmed	HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.	EGFR PKD1	6.37e-05	3	161	2	23152903
Pubmed	Tendon Extracellular Matrix Remodeling and Defective Cell Polarization in the Presence of Collagen VI Mutations.	COL6A1 COL6A2	6.37e-05	3	161	2	32053901
Pubmed	Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.	NRXN1 NLGN2	6.37e-05	3	161	2	17582332
Pubmed	Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.	SIGLEC1 IL2RG	6.37e-05	3	161	2	26429886
Pubmed	Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.	COL6A1 COL6A2	6.37e-05	3	161	2	25204870
Interaction	NCR3 interactions	COL6A1 COL6A2 FRAS1 MAN2B1 P3H3 CNTNAP1 LIPA FOXRED2 CELSR2 CLPTM1	3.44e-08	120	157	10	int:NCR3
Interaction	CFC1 interactions	COL6A1 COL6A2 FRAS1 P3H3 CNTNAP1 CEMIP MEGF8 CLPTM1 SEL1L3 NLGN2	5.49e-08	126	157	10	int:CFC1
Interaction	IL5RA interactions	COL6A2 FRAS1 MAN2B1 P3H3 FOXRED2 CELSR2 MEGF8 TENM3 EGFR	5.55e-07	124	157	9	int:IL5RA
Interaction	PRG2 interactions	COL6A1 COL6A2 FRAS1 MAN2B1 P3H3 PRSS12 DVL2 LIPA FOXRED2 CELSR2 AGT CLPTM1	2.50e-06	285	157	12	int:PRG2
Interaction	GGH interactions	PDXDC1 COL6A2 FRAS1 MAN2B1 P3H3 FOXRED2 MEGF8 EGFR CLPTM1 SEL1L3 PLXNB1	3.33e-06	243	157	11	int:GGH
Interaction	PCDHA7 interactions	PCDHA12 PCDHA7 PCDHA4 EGFR	3.34e-06	14	157	4	int:PCDHA7
Interaction	FBXO2 interactions	COL6A1 COL6A2 FRAS1 MAN2B1 CNTNAP1 CEMIP LIPA MEGF8 TENM3 EGFR MRC2 CLPTM1 SEL1L3 SLC12A7	4.28e-06	411	157	14	int:FBXO2
Interaction	PCDHA11 interactions	PCDHAC2 PCDHA12 PCDHA4 PCDHA1	1.25e-05	19	157	4	int:PCDHA11
Interaction	HMGCLL1 interactions	COL6A1 ADAMTS4 CYP51A1 CEMIP	1.56e-05	20	157	4	int:HMGCLL1
Interaction	TAFA2 interactions	COL6A2 CNTNAP1 TENM3 MRC2 NLGN2	3.17e-05	47	157	5	int:TAFA2
Interaction	ST8SIA4 interactions	FRAS1 PTCH1 CELSR2 EGFR MRC2 NLGN2	5.00e-05	84	157	6	int:ST8SIA4
Interaction	OS9 interactions	COL6A1 FRAS1 ADAMTS4 P3H3 PTCH1 FOXRED2 TENM3 EGFR PLPPR2	5.65e-05	219	157	9	int:OS9
Interaction	SIRPD interactions	COL6A2 FRAS1 P3H3 CELSR2 MEGF8 CLPTM1	5.71e-05	86	157	6	int:SIRPD
Interaction	CBLN4 interactions	COL6A2 FRAS1 P3H3 CEMIP LIPA CELSR2 MEGF8	6.23e-05	127	157	7	int:CBLN4
Interaction	PCDHA8 interactions	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	6.84e-05	55	157	5	int:PCDHA8
Interaction	NXPH3 interactions	COL6A2 FRAS1 CNTNAP1 CELSR2 NRXN1	8.84e-05	58	157	5	int:NXPH3
Interaction	LYPD1 interactions	COL6A1 COL6A2 FRAS1 MEGF8 CLPTM1	8.84e-05	58	157	5	int:LYPD1
Interaction	FOXRED2 interactions	NIPSNAP1 FOXRED2 MIPEP HERC1 USH2A CA6	1.06e-04	96	157	6	int:FOXRED2
Cytoband	5q31	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	3.48e-06	115	161	6	5q31
Cytoband	13q12	MTMR6 KL MIPEP	8.12e-05	24	161	3	13q12
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 CATSPER3 PCDHA1	9.41e-05	298	161	7	chr5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	CLEC18A TRADD CLEC18C CES2 HAS3	4.88e-04	183	161	5	chr16q22
Cytoband	16q22.1	CLEC18A CLEC18C CES2 HAS3	6.30e-04	110	161	4	16q22.1
GeneFamily	Clustered protocadherins	PCDHGC5 PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1	3.06e-06	64	114	6	20
GeneFamily	C-type lectin domain family	CLEC18A CLEC18B CLEC18C PLA2R1 MRC2	1.13e-05	47	114	5	494
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN ACAN	2.35e-04	4	114	2	574
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN CSMD3 ACAN C1S	4.58e-04	57	114	4	1179
GeneFamily	Transglutaminases	TGM6 TGM1	1.38e-03	9	114	2	773
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	BCAN ACAN PKD1	2.19e-03	41	114	3	1298
GeneFamily	Collagens	COL6A1 COL6A2 COL6A6	3.04e-03	46	114	3	490
GeneFamily	Fibronectin type III domain containing	ROBO4 MID1 CNTN3 USH2A IL2RG	3.45e-03	160	114	5	555
Coexpression	NABA_MATRISOME	CLEC18A COL6A1 COL6A2 DPT FRAS1 CLEC18B S100A16 ADAMTS4 COL6A6 P3H3 PRSS12 CLEC18C MMP21 BCAN TGM6 TGM1 SEMA3D OVGP1 MEGF8 FCN2 ACAN AGT FGA USH2A PLXNB1	3.59e-09	1026	160	25	M5889
Coexpression	NABA_MATRISOME	CLEC18A COL6A1 COL6A2 DPT FRAS1 CLEC18B S100A16 ADAMTS4 COL6A6 P3H3 PRSS12 CLEC18C MMP21 BCAN TGM6 TGM1 SEMA3D OVGP1 MEGF8 FCN2 ACAN AGT FGA PLXNB1	1.19e-08	1008	160	24	MM17056
Coexpression	WANG_MLL_TARGETS	COL6A1 COL6A2 DMBX1 CES2 TGM1 PLA2R1 MRC2 AGT DAPP1 MME FOXC1 FOXC2	2.79e-07	294	160	12	M2456
Coexpression	AIZARANI_LIVER_C20_LSECS_3	ROBO4 S100A16 ADAMTS4 SPAG9 PLEKHG1 SLC7A1 SSH1 FCN2 MID1 NCOA7 HERC1 FOXC1	2.89e-07	295	160	12	M39121
Coexpression	WANG_MLL_TARGETS	COL6A1 COL6A2 DMBX1 CES2 TGM1 PLA2R1 MRC2 AGT DAPP1 MME FOXC1 FOXC2	4.27e-07	306	160	12	MM1076
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	COL6A1 COL6A2 PRSS12 CNTNAP1 CAPZB SESN3 ATP8B1 PTCH1 SLC7A1 TMTC1 LIPA CNTN3 C1S FOXC2	1.07e-05	567	160	14	M2129
Coexpression	MARTINEZ_RB1_TARGETS_DN	ADAMTS4 PRSS12 CAPZB SIVA1 SHISA2 DUS1L LIPA CELSR2 ACAN PKD1 ALDH3A1 HAS3 HDC CA6	1.11e-05	569	160	14	M12701
Coexpression	NABA_MATRISOME_ASSOCIATED	CLEC18A CLEC18B S100A16 ADAMTS4 P3H3 PRSS12 CLEC18C MMP21 TGM6 TGM1 SEMA3D OVGP1 MEGF8 FCN2 AGT PLXNB1	1.25e-05	738	160	16	MM17058
Coexpression	NABA_MATRISOME_ASSOCIATED	CLEC18A CLEC18B S100A16 ADAMTS4 P3H3 PRSS12 CLEC18C MMP21 TGM6 TGM1 SEMA3D OVGP1 MEGF8 FCN2 AGT PLXNB1	1.55e-05	751	160	16	M5885
Coexpression	PGF_UP.V1_DN	NPR2 NOX1 FCN2 CLPTM1 PKD1 FGA ZFHX2 CACNA1H	2.29e-05	190	160	8	M2673
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	COL6A2 MAN2B1 ADAMTS4 PRSS12 SIVA1 SHISA2 DUS1L CELSR2 EGFR ACAN PKD1 ALDH3A1 FOXC1 CA6	2.41e-05	610	160	14	M3854
Coexpression	MARTINEZ_TP53_TARGETS_DN	COL6A2 MAN2B1 ADAMTS4 PRSS12 SIVA1 SHISA2 DUS1L CELSR2 EGFR ACAN PKD1 ALDH3A1 FOXC1 CA6	2.63e-05	615	160	14	M8673
Coexpression	MARTINEZ_RB1_TARGETS_DN	ADAMTS4 PRSS12 CAPZB SIVA1 SHISA2 DUS1L LIPA CELSR2 ACAN PKD1 ALDH3A1 HAS3 HDC CA6	3.42e-05	630	160	14	MM1038
Coexpression	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	COL6A1 COL6A2 P3H3 CAPZB SPAG9 CEMIP MTMR6 SSH1 EGFR MRC2 C1S	4.34e-05	407	160	11	M19541
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	COL6A2 MAN2B1 ADAMTS4 PRSS12 SIVA1 SHISA2 DUS1L CELSR2 EGFR ACAN PKD1 ALDH3A1 FOXC1 CA6	4.80e-05	650	160	14	MM1042
Coexpression	NABA_CORE_MATRISOME	COL6A1 COL6A2 DPT FRAS1 COL6A6 BCAN ACAN FGA USH2A	5.12e-05	275	160	9	M5884
Coexpression	NABA_ECM_AFFILIATED	CLEC18A CLEC18B CLEC18C SEMA3D OVGP1 FCN2 PLXNB1	5.46e-05	158	160	7	MM17063
Coexpression	MARTINEZ_TP53_TARGETS_DN	COL6A2 MAN2B1 ADAMTS4 PRSS12 SIVA1 SHISA2 DUS1L CELSR2 EGFR ACAN PKD1 ALDH3A1 FOXC1 CA6	5.56e-05	659	160	14	MM1040
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	DPT EFCAB6 DNAH2 B4GALT6 SLC7A1 CD3D SIPA1L1 KMT2A VAV3	5.73e-05	279	160	9	M16867
Coexpression	NABA_ECM_AFFILIATED	CLEC18A CLEC18B CLEC18C SEMA3D OVGP1 FCN2 PLXNB1	8.66e-05	170	160	7	M5880
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HOPC	SPATA6 PCDHA7 BCAN CSMD3 B4GALT6 NRXN1 EGFR SEL1L3 NLGN2 PLPPR2	8.89e-05	366	160	10	M39052
Coexpression	NABA_BASEMENT_MEMBRANES	COL6A1 COL6A2 COL6A6 USH2A	1.03e-04	40	160	4	M5887
Coexpression	AIZARANI_LIVER_C9_LSECS_1	ROBO4 COL6A2 S100A16 ADAMTS4 PLEKHG1 FCN2 MID1 NCOA7 HERC1	1.10e-04	304	160	9	M39113
Coexpression	HARRIS_BRAIN_CANCER_PROGENITORS	COL6A1 COL6A2 SHISA2 FOXC2	1.37e-04	43	160	4	M1694
Coexpression	HARRIS_BRAIN_CANCER_PROGENITORS	COL6A1 COL6A2 SHISA2 FOXC2	1.64e-04	45	160	4	MM1213
Coexpression	GSE10325_BCELL_VS_LUPUS_BCELL_UP	AMHR2 DPT SLC25A6 TGM1 SEMA3D AVIL ZNF778	1.96e-04	194	160	7	M3094
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	OXR1 SESN3 SHISA2 SPAG9 B4GALT6 TMTC1 KL NRXN1 AVIL KYNU	1.98e-04	404	160	10	M19488
Coexpression	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN	ATP8B1 KLHL31 FBH1 DNAAF10 AVIL MID1 SIGLEC1	2.22e-04	198	160	7	M4927
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	CAPZB SHISA2 COX18 SLC7A1 SIPA1L1 AVIL SEL1L3	2.29e-04	199	160	7	M6654
Coexpression	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP	MAN2B1 P3H3 SESN3 SPAG9 B4GALT6 LIPA SEL1L3	2.36e-04	200	160	7	M9354
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	PCDHA12 COX18 FBH1 XRN1 KMT2A NLGN2 CA6	2.36e-04	200	160	7	M3973
Coexpression	KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	LIPA OVGP1 IKBKE DNAAF10 PKD1 KMT2A SLC12A7	2.36e-04	200	160	7	M3012
Coexpression	DESCARTES_FETAL_EYE_STROMAL_CELLS	COL6A1 COL6A2 DPT ADAMTS4 COL6A6	2.43e-04	91	160	5	M40180
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL6A1 COL6A2 DPT PCDHA7 SHISA2 KLHL31 MRC2 GAL3ST3 C1S MME FOXC1	1.96e-11	163	160	11	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	droplet-Fat-Scat-21m\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT S100A16 COL6A6 BCO1 FCGBP MID1 SEL1L3 LTC4S	4.74e-10	165	160	10	3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT COL6A6 P3H3 SEMA3D TENM3 EGFR C1S	3.22e-08	191	160	9	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT COL6A6 P3H3 SEMA3D TENM3 EGFR C1S	3.22e-08	191	160	9	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 COL6A6 P3H3 ATP8B1 EGFR MRC2 C1S MME	3.36e-08	192	160	9	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	facs-Heart-RA-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 TENM3 EGFR MRC2 C1S FOXC2	3.68e-08	194	160	9	bc945450b350f597c3ff910d3a14a533d90086a8
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT ADAMTS4 P3H3 TENM3 EGFR C1S FOXC1	4.02e-08	196	160	9	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT ADAMTS4 P3H3 TENM3 EGFR C1S FOXC1	4.02e-08	196	160	9	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	COL6A1 COL6A2 DPT ADAMTS4 COL6A6 TENM3 EGFR MRC2 C1S	4.20e-08	197	160	9	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A1 COL6A2 DPT S100A16 EGFR MRC2 C1S NLGN2 FOXC1	4.38e-08	198	160	9	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT C1S CACNA1H FOXC2	4.58e-08	199	160	9	20f760d92c351a1dac4cc0a424c443ea03a179fe
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT C1S CACNA1H FOXC2	4.58e-08	199	160	9	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	distal-mesenchymal-Airway_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT C1S CACNA1H FOXC2	4.78e-08	200	160	9	f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 EFCAB6 TDRD9 CEMIP STRN NRXN1 ZFHX2 KYNU	1.15e-07	159	160	8	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 EFCAB6 TDRD9 CEMIP STRN NRXN1 ZFHX2 KYNU	1.15e-07	159	160	8	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS12 CYP51A1 GCM1 TGM1 AGT MME USH2A HDC	1.68e-07	167	160	8	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCell	droplet-Kidney-nan-18m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS12 CYP51A1 GCM1 TGM1 AGT MME USH2A HDC	1.84e-07	169	160	8	f00741203efa0b948db7223ee8c19bdd0918258a
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 P3H3 EGFR MRC2 AGT C1S MME	1.84e-07	169	160	8	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT CATSPER3 SEMA3D TENM3 C1S FOXC2	1.84e-07	169	160	8	031465190cd3623a25ef2b868daab8d932c8ff08
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT EGFR MRC2 AGT C1S MME	2.51e-07	176	160	8	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT EGFR MRC2 AGT C1S MME	2.51e-07	176	160	8	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	390C-Fibroblasts-Fibroblast-G\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL6A2 DPT FRAS1 COL6A6 TENM3 MRC2 C1S	2.98e-07	180	160	8	137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell	390C-Fibroblasts-Fibroblast-G-\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL6A2 DPT FRAS1 COL6A6 TENM3 MRC2 C1S	2.98e-07	180	160	8	cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A2 DPT ADAMTS4 PTCH1 ADCY5 CNTN3 C1S	3.11e-07	181	160	8	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 DUSP29 MRC2 C1S CA6	3.68e-07	185	160	8	785c55d39909fac74415f24427979691e7e694e6
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 DUSP29 MRC2 C1S CA6	3.68e-07	185	160	8	97a1dcacbc48dc3f41c26fbb59af35c935f894d4
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT P3H3 PTCH1 PM20D2 PLA2R1 AVIL	3.83e-07	186	160	8	827f2f2ddde315d1e5970dd56f906c555ec699af
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 FRAS1 P3H3 SEMA3D MRC2 C1S FOXC2	3.99e-07	187	160	8	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL6A2 FRAS1 PTCH1 CEMIP TMTC1 EGFR FOXC1	4.15e-07	188	160	8	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	IPF-Stromal-SMC\|World / Disease state, Lineage and Cell class	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT CACNA1H FOXC2	4.15e-07	188	160	8	b66264e8f8d536ed2beec31e6746c687718f239b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 COL6A2 DPT COL6A6 SEMA3D TENM3 MRC2 C1S	4.32e-07	189	160	8	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 SEMA3D EGFR MRC2 C1S	4.32e-07	189	160	8	f0a2d4ef9896d764971ebbc6952510c128bb76e8
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 SEMA3D EGFR MRC2 C1S	4.32e-07	189	160	8	378f26f751ab4b470948c35dd8347de72dd12ff7
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT P3H3 PLA2R1 MRC2 C1S MME	4.68e-07	191	160	8	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 EGFR MRC2 AGT C1S	4.68e-07	191	160	8	6cab0334f76c973880bd8d1638856f2f6e4a249a
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT P3H3 PLA2R1 MRC2 C1S MME	4.68e-07	191	160	8	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A1 COL6A2 DPT COL6A6 SEMA3D MRC2 MID1 C1S	4.87e-07	192	160	8	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT P3H3 SEMA3D EGFR MRC2 C1S	4.87e-07	192	160	8	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 COL6A2 DPT COL6A6 SEMA3D TENM3 MRC2 C1S	4.87e-07	192	160	8	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 NPR2 SHISA2 PLA2R1 MRC2 C1S MME	4.87e-07	192	160	8	ff4b728a55c2550c806c47e9ae3d057c35df8464
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 NPR2 SHISA2 PLA2R1 MRC2 C1S MME	4.87e-07	192	160	8	2d3790bd80a7f214b37094121a2a86ff16362569
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	COL6A1 COL6A2 DPT COL6A6 SEMA3D MRC2 MID1 C1S	4.87e-07	192	160	8	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 COL6A2 COL6A6 PRSS12 SEMA3D TENM3 MRC2 C1S	4.87e-07	192	160	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 EGFR MRC2 C1S MME	5.07e-07	193	160	8	316ebdf15f75d88c348f909b643fcd315364ca84
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT S100A16 P3H3 PRSS12 MRC2 C1S	5.07e-07	193	160	8	eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCell	droplet-Fat-Scat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 EGFR MRC2 C1S MME	5.07e-07	193	160	8	8dc6db335678f3a5cfd36026ad811fed8d9cb4bc
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT P3H3 PRSS12 SEMA3D TENM3 C1S	5.07e-07	193	160	8	051f61156b0e2e95292b2d8377faf3190b50f264
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 EGFR MRC2 C1S MME	5.07e-07	193	160	8	1afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A1 SPATA6 COL6A6 SHISA2 PLA2R1 SEMA3D CNTN3 MME	5.27e-07	194	160	8	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	COL6A1 COL6A2 DPT ADAMTS4 COL6A6 TENM3 EGFR C1S	5.70e-07	196	160	8	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	COL6A1 COL6A2 DPT COL6A6 P3H3 TENM3 MRC2 C1S	5.70e-07	196	160	8	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT P3H3 EGFR MRC2 C1S ALDH3A1	5.70e-07	196	160	8	d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A1 COL6A2 CEMIP CELSR2 MEGF8 MRC2 PKD1 C1S	5.70e-07	196	160	8	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A1 COL6A2 CLEC18C PLA2R1 ACAN CACNA1H FOXC1 FOXC2	5.70e-07	196	160	8	73f029d2b276776d6c24356b14c6592c9cb74bd5
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL6A2 DPT BCAN SEMA3D TENM3 MRC2 C1S	6.15e-07	198	160	8	bfd720e2dae3b6b3dc2bf8b2096c554fd456e756
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT CACNA1H FOXC2	6.15e-07	198	160	8	705118a5db366b43ffd3389c60e4cb392ad3f2e6
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL6A1 COL6A2 FRAS1 COL6A6 PLA2R1 TENM3 MRC2 C1S	6.15e-07	198	160	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A1 COL6A2 COL6A6 PRSS12 PTCH1 TENM3 MRC2 C1S	6.39e-07	199	160	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN AGT CACNA1H FOXC2	6.39e-07	199	160	8	ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A1 COL6A2 COL6A6 PRSS12 PTCH1 SEMA3D MRC2 C1S	6.39e-07	199	160	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 COL6A2 DPT COL6A6 PRSS12 PTCH1 SEMA3D MRC2	6.63e-07	200	160	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL6A1 COL6A2 DPT FRAS1 COL6A6 SEMA3D MRC2 C1S	6.63e-07	200	160	8	93c1db92e0e456101f7895867fc8a1fe45298347
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL6A1 COL6A2 DPT FRAS1 COL6A6 SEMA3D MRC2 C1S	6.63e-07	200	160	8	46d0ae385e67030bfaf7062bb6b43da5db05b33a
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL6A2 FRAS1 DACT2 PTCH1 EGFR FOXC1 FOXC2	6.63e-07	200	160	8	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	COL6A2 RNF213 PTCH1 CD3D XRN1 KMT2A NCOA7 IL2RG	6.63e-07	200	160	8	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Parenchyma_COVID-19-Stromal-TX-Mesothelial-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL6A1 COL6A2 DPT FRAS1 COL6A6 SEMA3D MRC2 C1S	6.63e-07	200	160	8	3be373e9a30e19334e4709e2819fb83cc777d104
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 COL6A2 DPT COL6A6 PRSS12 PTCH1 SEMA3D MRC2	6.63e-07	200	160	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT MAN2B1 SEMA3D EGFR C1S	2.29e-06	165	160	7	4e13fccd32029e2879e85f8966e582a46c09e4aa
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 EFCAB6 TDRD9 CEMIP STRN NRXN1 KYNU	2.38e-06	166	160	7	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 EFCAB6 TDRD9 CEMIP STRN NRXN1 KYNU	2.38e-06	166	160	7	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT MAN2B1 SEMA3D EGFR C1S	2.48e-06	167	160	7	fe3338f99f94c0dac37e3d649dfdce82e4a56022
ToppCell	droplet-Kidney-nan-3m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMHR2 NPR2 PRSS12 CYP51A1 GCM1 AGT MME	2.79e-06	170	160	7	dd48fd3c5c67eb71183981f42975a538f12077c3
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL6A2 DPT SEMA3D TENM3 C1S FOXC2	2.90e-06	171	160	7	15cb4670ff4234ac46aea8a5911138d6913c4482
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 FRAS1 PRSS12 SEMA3D TENM3 OTOF C1S	3.13e-06	173	160	7	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 FRAS1 COL6A6 PRSS12 SEMA3D OTOF C1S	3.25e-06	174	160	7	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	wk_08-11-Mesenchymal-Chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	DPT PLEKHG1 TENM3 ACAN MME FOXC1 FOXC2	3.51e-06	176	160	7	1af28b701c4598ce761f85adbd5d79e4918d265a
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FRAS1 PRSS12 NRXN1 EGFR CNTN3 ALDH3A1 PLXNB1	3.78e-06	178	160	7	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 P3H3 SHISA2 PTCH1 TENM3 MRC2 FOXC2	3.78e-06	178	160	7	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	COL6A1 COL6A2 DPT SPATA6 COL6A6 EGFR MRC2	3.92e-06	179	160	7	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	Control-Stromal-SMC\|Control / Disease state, Lineage and Cell class	COL6A1 COL6A2 ADAMTS4 ADCY5 AGT CACNA1H FOXC2	3.92e-06	179	160	7	1378051bc62009eec2dbecf3d5d89baedbeb84eb
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP95 WDR54 CES2 RSPH1 PLAAT2 TUBA4B ALDH3A1	4.07e-06	180	160	7	adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 FRAS1 CNTNAP1 BCO1 SEMA3D STRN C1S	4.22e-06	181	160	7	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	COL6A1 COL6A2 ADAMTS4 CNTNAP1 ACAN CACNA1H FOXC2	4.22e-06	181	160	7	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 FRAS1 CNTNAP1 BCO1 SEMA3D STRN C1S	4.22e-06	181	160	7	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 MRC2 FGA C1S	4.37e-06	182	160	7	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEMIP PLEKHG1 SLC7A1 SEMA3D SSH1 ALDH3A1 FOXC1	4.37e-06	182	160	7	f231e86524b628e6e11ac33d5c34be99d454a92a
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	COL6A1 COL6A2 ADAMTS4 ADCY5 ACAN CACNA1H FOXC2	4.53e-06	183	160	7	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 SEMA3D MRC2 C1S	4.70e-06	184	160	7	3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CLEC18A CLEC18B CLEC18C TMTC1 TENM3 ACAN FOXC1	4.87e-06	185	160	7	8ed10ba581849c9c4ac4397226be2b62b4b3b900
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 COL6A2 DPT P3H3 SEMA3D TENM3 FOXC2	4.87e-06	185	160	7	c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CLEC18A CLEC18B CLEC18C TMTC1 TENM3 ACAN FOXC1	4.87e-06	185	160	7	b8052cebb73f41abe6faf0aa847be7c8ef23ae94
ToppCell	droplet-Kidney-nan-21m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 SEMA3D MRC2 C1S	4.87e-06	185	160	7	33cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 COL6A2 DPT CFAP95 ADAMTS4 P3H3 CACNA1H	4.87e-06	185	160	7	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT BCO1 SEL1L3 C1S LTC4S	4.87e-06	185	160	7	01bbe1e09f9ccae837a03ea2cdd168fa10800942
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 SEMA3D MRC2 C1S	4.87e-06	185	160	7	9954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 MRC2 FGA C1S	5.04e-06	186	160	7	35c88cc4eb388811fcac4323b549e5897fa8dc27
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 DUSP29 MRC2 C1S	5.04e-06	186	160	7	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL6A2 DPT ADAMTS4 COL6A6 MRC2 C1S	5.04e-06	186	160	7	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 COL6A2 DPT P3H3 MRC2 FGA C1S	5.04e-06	186	160	7	d998c5b00083cf2a7cd5341a98b7374b4de73c63
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP51A1 BCO1 CEMIP PLEKHG1 TGM1 AVIL ALDH3A1	5.04e-06	186	160	7	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
Drug	Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A	CHRNG CAPN10 BCO1 PLA2R1 STRN TENM3 AGT MID1 PLAAT2 PLXNB1	1.52e-06	199	160	10	5542_UP
Disease	visceral adipose tissue measurement, body mass index	PCDHAC2 PCDHA12 PCDHA7 PCDHA4 PCDHA1 MIPEP	7.84e-06	87	159	6	EFO_0004340, EFO_0004765
Disease	1,5 anhydroglucitol measurement	PCDHA12 PCDHA7 PCDHA4 PCDHA1	1.74e-05	29	159	4	EFO_0008009
Disease	cerebellar hyplasia/atrophy, epilepsy, and global developmental delay (implicated_via_orthology)	OXR1 NCOA7	2.89e-05	2	159	2	DOID:0070339 (implicated_via_orthology)
Disease	Ullrich congenital muscular dystrophy	COL6A1 COL6A2	1.72e-04	4	159	2	cv:C4551860
Disease	Bethlem myopathy	COL6A1 COL6A2	1.72e-04	4	159	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A1 COL6A2	1.72e-04	4	159	2	C1834674
Disease	MRNA-decapping enzyme 1A measurement	COL6A1 COL6A2	1.72e-04	4	159	2	EFO_0802757
Disease	Ullrich congenital muscular dystrophy 1	COL6A1 COL6A2	1.72e-04	4	159	2	C0410179
Disease	Gilles de la Tourette syndrome	CHD2 HDC	1.72e-04	4	159	2	C0040517
Disease	Bethlem myopathy (is_implicated_in)	COL6A1 COL6A2	1.72e-04	4	159	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A1 COL6A2	1.72e-04	4	159	2	DOID:0050558 (is_implicated_in)
Disease	achondroplasia (implicated_via_orthology)	NPR2 ACAN	4.27e-04	6	159	2	DOID:4480 (implicated_via_orthology)
Disease	complement C1s subcomponent measurement	P3H3 C1S	4.27e-04	6	159	2	EFO_0008091
Disease	centronuclear myopathy (implicated_via_orthology)	KLHL31 MTMR6	5.95e-04	7	159	2	DOID:14717 (implicated_via_orthology)
Disease	Spinocerebellar Ataxia Type 2	TGM6 MME FOXC1	8.13e-04	34	159	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	TGM6 MME FOXC1	8.13e-04	34	159	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	TGM6 MME FOXC1	8.13e-04	34	159	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	TGM6 MME FOXC1	8.13e-04	34	159	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	TGM6 MME FOXC1	8.13e-04	34	159	3	C0752124
Disease	Ataxia, Spinocerebellar	TGM6 MME FOXC1	8.13e-04	34	159	3	C0087012
Disease	IGA Glomerulonephritis	MAN2B1 AGT VAV3	8.13e-04	34	159	3	C0017661
Disease	Spinocerebellar Ataxia Type 4	TGM6 MME FOXC1	8.85e-04	35	159	3	C0752122
Disease	post-traumatic stress disorder symptom measurement	PCDHA7 PCDHA4 PCDHA1 ADCY5	1.02e-03	82	159	4	EFO_0008535
Disease	Abnormality of refraction	COL6A1 TPRA1 TDRD9 PCDHA12 PCDHA7 PCDHA4 PCDHA1 ADCY5 CHRNG ZGPAT VAV3	1.10e-03	673	159	11	HP_0000539
Disease	degenerative disc disease (biomarker_via_orthology)	ADAMTS4 ACAN	1.54e-03	11	159	2	DOID:90 (biomarker_via_orthology)
Disease	Neurodevelopmental Disorders	CHD2 ADCY5 KMT2A PLXNB1	1.63e-03	93	159	4	C1535926
Disease	hyperinsulinism (is_implicated_in)	AGT PARL	1.84e-03	12	159	2	DOID:2018 (is_implicated_in)
Disease	multiple sclerosis (is_marker_for)	B4GALT6 ACAN AGT	2.36e-03	49	159	3	DOID:2377 (is_marker_for)
Disease	Pneumoconiosis	OVGP1 ACAN	2.52e-03	14	159	2	C0032273
Disease	Bagassosis	OVGP1 ACAN	2.52e-03	14	159	2	C0004681
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 KIF28P	2.52e-03	14	159	2	DOID:898 (implicated_via_orthology)
Disease	severe combined immunodeficiency (is_implicated_in)	CD3D IL2RG	2.52e-03	14	159	2	DOID:627 (is_implicated_in)
Disease	polycystic kidney disease (implicated_via_orthology)	AGT PKD1	2.52e-03	14	159	2	DOID:0080322 (implicated_via_orthology)
Disease	TPE interval measurement	DPT STRN NCOA7	2.80e-03	52	159	3	EFO_0004644
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	FRAS1 NRXN1 ASB7 SIPA1L1	3.01e-03	110	159	4	EFO_0803335
Disease	Cardiovascular Abnormalities	AGT FOXC2	3.29e-03	16	159	2	C0243050
Disease	Tetralogy of Fallot	FOXC1 FOXC2	3.29e-03	16	159	2	C0039685
Disease	pulse pressure measurement	COL6A1 CYP51A1 CLEC18C PCDHA12 RNF213 PCDHA7 PCDHA4 CHD2 PCDHA1 ADCY5 PLEKHG1 CD3D MEGF8 MRC2 PKD1 UBR3	3.57e-03	1392	159	16	EFO_0005763
Disease	neuroticism measurement, cognitive function measurement	NIPSNAP1 PCDHA12 PCDHA7 PCDHA4 PCDHA1 PTCH1 STRN TENM3 SIPA1L1	3.71e-03	566	159	9	EFO_0007660, EFO_0008354
Disease	Multiple congenital anomalies	NRXN1 KYNU	3.72e-03	17	159	2	C0000772
Disease	Renal Insufficiency	AGT MME	3.72e-03	17	159	2	C1565489
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	PDXDC1 SLC46A1 MAU2 CELSR2 SIPA1L1 CLPTM1	3.80e-03	274	159	6	EFO_0004530, EFO_0004612
Disease	Post-Traumatic Osteoporosis	ADCY5 KL FGA	4.40e-03	61	159	3	C0751406
Disease	Osteoporosis, Senile	ADCY5 KL FGA	4.40e-03	61	159	3	C0029459
Disease	Osteoporosis, Age-Related	ADCY5 KL FGA	4.40e-03	61	159	3	C0001787
Disease	Hydrops Fetalis	LIPA FOXC2	4.65e-03	19	159	2	C0020305
Disease	inflammatory bowel disease (is_implicated_in)	EGFR AGT	4.65e-03	19	159	2	DOID:0050589 (is_implicated_in)
Disease	level of Sterol ester (27:1/20:3) in blood serum	PDXDC1 NRXN1	4.65e-03	19	159	2	OBA_2045199
Disease	Omenn Syndrome	CD3D IL2RG	4.65e-03	19	159	2	C2700553
Disease	Osteoporosis	ADCY5 KL FGA	4.81e-03	63	159	3	C0029456
Disease	docosahexaenoic acid measurement	PDXDC1 MAU2 CELSR2 VAV3	5.02e-03	127	159	4	EFO_0007761
Disease	acylcarnitine measurement	DVL2 CPT2 HERC1 USH2A	5.02e-03	127	159	4	EFO_0005059
Disease	glomerulonephritis (biomarker_via_orthology)	AGT LTC4S	5.14e-03	20	159	2	DOID:2921 (biomarker_via_orthology)
Disease	Severe Combined Immunodeficiency	CD3D IL2RG	5.14e-03	20	159	2	C0085110
Disease	esterified cholesterol measurement	PDXDC1 CELSR2 SSH1 CLPTM1	5.16e-03	128	159	4	EFO_0008589
Disease	hypertension (implicated_via_orthology)	KL AGT MME KYNU	5.16e-03	128	159	4	DOID:10763 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
GDLIEISRFGYAHWA	PLAAT2	11	Q9NWW9
LQWAHSYADGLQQGD	ERVPABLB-1	66	P60509
HTQFWRYFAGNLASG	SLC25A6	106	P12236
DDAQYSHLGGNWARN	CD3D	156	P04234
YIWQGRHASQDELAA	AVIL	441	O75366
LQFAAGYRLNDGFWH	CNTNAP1	431	P78357
GYRLNDGFWHEVNFV	CNTNAP1	436	P78357
SGFGYDHLILNVEWA	EIF3G	301	O75821
VSAVHANGWYEALAA	COX18	46	Q8N8Q8
TGLYDALLGAWHTQI	COG7	251	P83436
NGRDANGWTLLHFSA	ASB7	41	Q9H672
DHDNWGNLAAAFFTL	CATSPER3	206	Q86XQ3
TEHNWDSLDFYDGGD	CSMD3	1986	Q7Z407
SHFDNGNEEWFLVGR	CHRNG	456	P07510
GALAADLHKNEWNAY	ALDH3A1	46	P30838
GHYGAFLQDEWDLLQ	DUS1L	116	Q6P1R4
SYEHLWAGQVADALV	CAPN10	161	Q9HC96
WEELQFGNSERYHKG	NPR2	496	P20594
HDYSDDGWVNLNRQG	DPT	31	Q07507
EGGTAWLLQHYEAYA	CELSR2	2131	Q9HCU4
LAQPHNWSADEGGFA	SLC7A4	216	O43246
RDFTNYGLEHWGSDT	DUS3L	551	Q96G46
AWGEADSRANGYPHA	ADCY5	31	O95622
VSSVYLWDLDHGFAG	CAPZB	116	P47756
FLLGGQAQHVSDWTY	CA6	11	P23280
AYKNQDHGAWLRGGD	CEMIP	786	Q8WUJ3
NAFLGSDVVDWLYHH	DVL2	451	O14641
LSAGLAIGHAYWEAQ	ATP8B1	351	O43520
GLAFLHEERWQNGQY	AMHR2	311	Q16671
LAWAGLAAGDRVYIH	AGT	16	P01019
EHSWGDGVAVLRFFN	CPT2	371	P23786
HWAAYDTGLELLGRQ	P3H3	216	Q8IVL6
GQWDLSNYHLLDLGR	SPAG9	1031	O60271
RFGINTWHDESGIYA	CFAP95	196	Q5VTT2
GWDSNIVGHAALNFD	NOX1	476	Q9Y5S8
LAAWEAGRGQLHYSV	PCDHA7	21	Q9UN72
TTGQLYAAWDGGLDH	BCAN	286	Q96GW7
EGLWLHIDAAYAGTA	HDC	266	P19113
LGLSGIAKAWHQAYF	PRSS12	321	P56730
SLLGGHWLRAQGYAN	SLC46A1	196	Q96NT5
SALHGRAYLVGGWNE	KLHL31	561	Q9H511
YEGHVFQDGEDWRLS	FRAS1	161	Q86XX4
NDFYSGLESSGWLRH	MTMR6	296	Q9Y217
EHTLALASNGDVYAW	HERC1	4301	Q15751
NYLWHTDDLLGQGAT	IKBKE	6	Q14164
RYLATGDFGGNLHIW	DNAAF10	81	Q96MX6
WNYSGDLGARVALHE	PLXNB1	2076	O43157
TLWVAGIFFHEGAAA	LTC4S	66	Q16873
AFDGSGQEFAHAWRL	MMP21	241	Q8N119
DADAGHNAWLSYSLL	PCDHGC5	596	Q9Y5F6
NWSGIGVVRYEHAND	PDXDC1	516	Q6P996
ADGIQDYWADHLQLG	FAM205A	191	Q6ZU69
HATGNWGYLDQVAAL	CES2	191	O00748
YGNFSWDLAGGQHLN	MME	626	P08473
GHAAALVDDVWLYVS	MEGF8	336	Q7Z7M0
EHLQSYEGQSRGAWL	MRC2	1316	Q9UBG0
AAAAQAASWYLNHSG	FOXC2	416	Q99958
NDGEWYHVDFQRDGR	NRXN1	571	Q9ULB1
GGSILNEYWVLSAAH	PRSS38	86	A1L453
WATHYVGDLRAINNG	FOXRED2	251	Q8IWF2
TTWNGLLYAIGGHDA	KLHL5	651	Q96PQ7
AYEDGFHQCDAGWLA	ACAN	191	P16112
LAAWEVGSGQLHYSI	PCDHA1	21	Q9Y5I3
VAEYRNHWSDVLAGF	PLPPR2	256	Q96GM1
NHWSDVLAGFLTGAA	PLPPR2	261	Q96GM1
DSDSGQNAWLFYHLA	PCDHAC2	611	Q9Y5I4
GEFALWLDGDLYHGR	OXR1	831	Q8N573
LAAWEAGNGQLHYSV	PCDHA4	21	Q9UN74
AARTWNALDAGLYDH	GAL3ST3	286	Q96A11
GENNTLVWKYADAGH	EGFR	601	P00533
SLHWDGGALLGVLQY	ADAMTS4	141	O75173
HLPDLYAAAGGVNIW	FBH1	331	Q8NFZ0
ALGYVAAGHAELAWT	DACT2	716	Q5SW24
GGEDDDLWNRVHYAG	B4GALT6	291	Q9UBX8
DRNLVWNAGALHYSD	COL6A1	81	P12109
NAAHGRWNVDTGPDY	DUSP29	86	Q68J44
SWGVSRHDNAINYLD	EFCAB6	1011	Q5THR3
LGSINWAFLGVDEAH	CHD2	606	O14647
ANGTYHEAGSEFWAD	FCGBP	2011	Q9Y6R7
GEFWLGNDNIHALTA	FCN2	171	Q15485
TSWYLNQAGGDLGHL	FOXC1	471	Q12948
YQSLSAAAAAHQGVW	DMBX1	321	Q8NFW5
ALSWRYGGLHFSDQV	COL6A2	91	P12110
QLYADLDGGFSHAAW	CYP51A1	231	Q16850
EAELLQDLGWYHGNL	DAPP1	26	Q9UN19
GVYSDHGDLQAWSKN	GCM1	286	Q9NP62
GGALINEYWVLTAAH	C1S	461	P09871
DEGEGEFWLGNDYLH	FGA	701	P02671
WAGNEAYAEYHFRVG	FGA	731	P02671
LEDLVTEYHGNFSAW	IL2RG	296	P31785
HVANDYARQLAAGWG	MAN2B1	456	O00754
QDAYGGWANRALADH	KL	201	Q9UEF7
GWANRALADHFRDYA	KL	206	Q9UEF7
DAGRLLYIGQNEWTH	KMT2A	1886	Q03164
AGFFVWRSNFHEAGE	HAS3	146	O00219
EHAYLQSSWNLLDGL	CACNA1H	1356	O95180
AGINYGGHVTDDWDR	DNAH2	4041	Q9P225
LENLWSTYAHAGAFV	SLC12A7	376	Q9Y666
AADSWYLALLGFAEH	MAU2	21	Q9Y6X3
ALRWLSENIAHFGGD	NLGN2	241	Q8NFZ4
AFLSWVEGRHFSDQG	PEX1	56	O43933
SNGHLLGYEVRYWNG	CNTN3	831	Q9P232
LAYWSHNGFQRDKDG	KIF28P	56	B7ZC32
NGDAFIGHALQWTLD	COL6A6	2056	A6NMZ7
HSLTGEGNFNWRYLF	OTOF	1781	Q9HC10
VAFLWTFGDGEQALH	PKD1	1051	P98161
DFINVLSYDLHGSWE	OVGP1	206	Q12889
LAAWEVGSGQLHYSV	PCDHA12	21	Q9UN75
DHAAHLGGALFGIWY	PARL	331	Q9H300
YGEQDQAVHLWRFSG	NIPSNAP1	116	Q9BPW8
NAHWLTYSLLRDGFE	USH2A	1081	O75445
LGHTDAVWGLAYSAA	STRN	566	O43815
GLNAYLEGSWHEALL	SEL1L3	881	Q68CR1
NGHEEWVGSAYLFVE	TRADD	6	Q15628
GHFWGYRIDENNSEI	TDRD9	911	Q8NDG6
FGLWLDADLYHGRSN	NCOA7	901	Q8NI08
HYFRDWLQGLQDAFD	PTCH1	846	Q13635
HWNYFGADENLGPVA	SIPA1L1	501	O43166
ARASGEYCHGWLDAQ	SHISA2	31	Q6UWI4
LQSHFGEKNGSWLYA	POLH	286	Q9Y253
DFGGRVVNNDHFLYW	ARHGAP5	61	Q13017
HFLYWGDIIQNSEDG	ARHGAP5	71	Q13017
DGSRYEGEWANDLRH	RSPH1	86	Q8WYR4
HSASYPWEGLNALDA	PM20D2	216	Q8IYS1
NRLGYAHWIGLFTTD	PLA2R1	1166	Q13018
QSAELGGLHWGQDYE	ROBO4	306	Q8WZ75
DISEHYWLNGAKFIG	SEMA3D	231	O95025
LIFDHLYLGSEWNAS	SSH1	311	Q8WYL5
EDAANNYAWGHYTIG	TUBA4B	36	Q9H853
TVGESRYNHWFDGLA	BCO1	41	Q9HAY6
TSALFWEQHDLVYGD	CLPTM1	121	O96005
LWFAEGQRYSHAAGE	CLEC18A	126	A5D8T8
LWFAEGQRYSHAAGE	CLEC18B	126	Q6UXF7
LWFAEGQRYSHAAGE	CLEC18C	126	Q8NCF0
GGFAAEWLSQEYFHR	RNF213	3276	Q63HN8
GDAFLIWQDQGYFVH	TMEM86A	81	Q8N2M4
EDFNIYGHGGRQFWL	TPRA1	181	Q86W33
FARSALWDSGLDYLH	XPNPEP1	471	Q9NQW7
YLQARAGSHNGEETW	ZNF778	211	Q96MU6
YGRSLQGEFVHDDVW	TMTC1	41	Q8IUR5
EERHGAFWSYQLAPN	ZFHX2	201	Q9C0A1
TAWQLRFSHLVGYGA	MIPEP	616	Q99797
SHRGLASAAGEFLYW	STAG3	436	Q9UJ98
FGYGLWHSEEASLDA	SLC7A1	601	P30825
WENHGFSLVNRLYSD	SESN3	356	P58005
SFYIAGDNDDHQWEA	SYCP2	316	Q9BX26
LDANHDGRISFDEYW	S100A16	66	Q96FQ6
AGNVFIDSGRHYWEV	MID1	531	O15344
WDHYGSNYALGAANI	XRN1	1541	Q8IZH2
LAWEAHVYGVGALFG	PRRT4	361	C9JH25
LDSGIWHLAFYNDGK	TENM3	486	Q9P273
DQAGHIRLTYFGQWS	RPS6KL1	421	Q9Y6S9
ARFSWYLNGALLHEG	SIGLEC1	541	Q9BZZ2
TGGAFALSHQSEDWY	PROP1	181	O75360
FCLWGSVYLDAHGEE	UBR3	1831	Q6ZT12
LYLGGDWQFNHFSKL	USP17L7	6	P0C7H9
RTWNYGQFDHGVLDA	TGM1	286	P22735
GDWLLHSTYSNGELA	PLEKHG1	1081	Q9ULL1
DNAWRGAEAYHFFIL	WDR35	1021	Q9P2L0
LFLGAQAYLDHVWDE	SIVA1	46	O15304
GTFHLDDGEYWSNRA	SPATA6	436	Q9NWH7
HIRAQGWNYGQFEED	TGM6	171	O95932
GLWHAARITDVDNGY	ZGPAT	231	Q8N5A5
YWHALDSGDASPVQA	WDR54	106	Q9H977
DAHSLFWQGRNLASG	VAV3	631	Q9UKW4
GNVELYLHDWGVDFA	KYNU	256	Q16719
SGGHDWLADVYDVNI	LIPA	341	P38571